Jeffrey Tangney on AI monetization strategy
From $DOCS Doximity Q4 2026 Earnings Conference Call · · EARNMOAR
“We've forecasted minimal AI revenue contribution this fiscal year while allowing for a wider range of AI investments and related expenses, meaning higher R&D, compute, and marketing spend that will weigh on near-term margins. We think that's the right trade. Longer term, we believe AI search alone represents a multi-billion dollar new TAM on top of the existing pharma marketing budgets we serve today.”
On , Jeffrey Tangney, Co-Founder, Chief Executive Officer & Chairperson at DOXIMITY INC, spoke about AI monetization strategy during $DOCS Doximity Q4 2026 Earnings Conference Call on EARNMOAR.
About Jeffrey Tangney
During Doximity’s fiscal 2026 fourth quarter earnings call on May 13, 2026, Tangney reported that nearly half of all U.S. doctors now work at hospitals that use Doximity’s workflow or scheduling tools, and that benchmark workflow engagement reached over 800,000 unique quarterly active prescribers, up roughly 30% year-over-year. He described this as a significant acceleration from the high single-digit growth seen a year earlier. Tangney also stated that the company paid $63 million for Pathway AI the previous summer and characterized the current period as “our AI investment year,” adding that Doximity had forecast minimal AI revenue contribution for the fiscal year while increasing spending on R&D, compute, and marketing. Tangney noted that the average Doximity AI search is 23 words, compared to an average Google search of two and a half words, and said the specificity of those searches provides a “whole new level” of insight. He attributed some shorter-duration client buys to policy and macroeconomic uncertainty, stating that many companies “want to retain optionality.”